References
- Arima, K., Kakinuma, A. and Tamura, G. (1968), Surfactin, a crystalline peptidolipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation, Biochem. Res. Commun., 31, 488-494 https://doi.org/10.1016/0006-291X(68)90503-2
- Banat, I.M., Makkar, R.S. and Cameotra, S.S. (2000), Potential commercial applications of microbial surfactants, Appl. Microbiol. Biotechnol., 53, 495-508 https://doi.org/10.1007/s002530051648
- Dearfield, K.L., Cimino, M.C., McCarroll, N.E., Mauer, I. and Valcovic, L.R. (2002), Genotoxicity risk assessment: a proposed classification strategy, Mutat. Res., 521, 121-135 https://doi.org/10.1016/S1383-5718(02)00236-X
- Desai, J.D. and Banat, I.M. (1997), Microbial production of surfactants and their commercial potential, Microbiol. Mol. Biol. Rev., 61, 47-64
- Galloway, S., Aardema, M., Ishidate, M., Ivett, J., Kirkland D., Morita, T., Mosesso, P. and Sofuni, T. (1994), Report from the working group on in vitro tests for chromosomal aberrations, Mutat. Res., 312, 241-262 https://doi.org/10.1016/0165-1161(94)00012-3
- Georgiou, G., Liu, S.C. and Sharma, M.M. (1990), Surface active compounds from microorganisms, Biotechnol., 10, 60-65 https://doi.org/10.1038/nbt0192-60
- Hwang, M.H., Lim, J.H., Kim, K.S., Rhee, M.H., Kim, N.W., Kim, J.C. and Park, S.C. (2005a), Antibacterial activity in vitro and primary dermal irritationtest in rabbits of surfactin produced in bacillus subtilus complex BC2121, J. Toxicol. Pub. Health, 20, 39-43
- Hwang, M.H., Lim, J.H., Yun, H.I., Rhee, M.H., Cho, J.Y., Hsu, W.H. and Park, S.C. (2005b), Surfactin C inhibits the lipopolysaccharide- induced transcription of interleukin-1beta and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cells, Biotechnol Lett., 27, 1605-1608 https://doi.org/10.1007/s10529-005-2515-1
- Hwang, Y.H., Park, B.K., Lim, J.H., Kim, M.S., Song, I.B., Park, S.C. and Yun, H.I. (2008), Evaluation of genetic and developmental toxicity of surfactin C from Bacillus subtilis BC1212, J. Health Sci., 54, 101-106 https://doi.org/10.1248/jhs.54.101
- Kanatomo, S., Nagai, S., Ohki, K. and Yasuda, Y. (1995), Study on surfactin, a cyclic depsipeptide. I. Isolation and structure of eight surfuctin analogs produced by Bacillus natto KMD 2311, Yakugaku. Zasshi., 115, 756-764 https://doi.org/10.1248/yakushi1947.115.9_756
- Kikuchi, T. and Hasumi, K. (2002), Enhancement of plasminogen activation surfactin C: augmentation of fibrinolysis in vitro and in vivo, Biochem. Biophys. Acta., 1596, 234-245 https://doi.org/10.1016/S0167-4838(02)00221-2
- Lim, J.H., Park, B.K., Kim, M.S., Hwang, M.H., Rhee, M.H., Park, S.C. and Yun, H.I. (2005), The anti-thrombotic activity of surfactins, J. Vet. Sci., 6, 353-355
- Mulligan, C.N. (2005), Environmental applications for biosurfactants, Environ Pollut., 133, 183-198 https://doi.org/10.1016/j.envpol.2004.06.009
- O'Brien, P.J., Hales, B.F., Josephy, P.D., Castonguay, A., Yamazoe, Y. and Guengerich, F.P. (1996), Chemical carcinogenesis, mutagenesis and teratogenesis, Can. J. Physiol. Pharmacol., 74, 565-571 https://doi.org/10.1139/cjpp-74-5-565
- Organization for Economic Cooperation and Development(OECD, 1997). Test Guideline 473, In vitro Mammalian chromosome aberration test. In: OECD Guidelines for the Testing of Chemicals. OECD Paris
- Park, B.K., Lim, J.H., Hwang, Y.H., Kim, M.S., Song, I.B., Lee, H.G., Han, S.J., Hwang, M.H., Kim, J.W., Park, S.C., Rhee, M.H. and Yun, H.I. (2006), Acute oral toxicity of surfactin C in mice, J. Toxicol. Pub. Health, 22, 453-458
- Rodrigues, L., Banat, I.M., Teixeira, J. and Oliveira, R. (2006), Biosurfactants: potential applications in medicine, J. Antimicrob.Chemother., 57, 609-618 https://doi.org/10.1093/jac/dkl024
- Singh, P. and Cameotra, S.S. (2004), Potential applications of microbial surfactants in biomedical sciences, Trends Biotechnol.,22, 142-146 https://doi.org/10.1016/j.tibtech.2004.01.010
- Scott, D., Danford, N., Dean, B., Kirkland, D. and Richardson C. (1983), In vitro chromosome aberration assays, Report of the UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Part 1, Cambridge University Press, Cambridge, UK, pp. 41-64
- Takahashi, T., Ohno, O., Ikeda, Y., Sawa, R., Homma, Y., Igarashi, M. and Umezawa, K. (2006), Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin, J. Antibiot (Tokyo), 59, 35-43 https://doi.org/10.1038/ja.2006.6